Oral Nanomedicine: Challenges and Opportunities

Compared to injection administration, oral administration is free of discomfort, wound infection, and complications and has a higher compliance rate for patients with diverse diseases. However, oral administration reduces the bioavailability of medicines, especially biologics (e.g., peptides, proteins, and antibodies), due to harsh gastrointestinal biological barriers. In this context, the development and prosperity of nanotechnology have helped improve the bioactivity and oral availability of oral medicines. On this basis, first, the biological barriers to oral administration are discussed, and then oral nanomedicine based on organic and inorganic nanomaterials and their biomedical applications in diverse diseases are reviewed. Finally, the challenges and potential opportunities in the future development of oral nanomedicine, which may provide a vital reference for the eventual clinical transformation and standardized production of oral nanomedicine, are put forward. This review discusses the impact of biological barriers (the gastric acid and intestinal mucosal barrier) on the bioavailability of oral medicine in the delivery process. Notably, nanotechnology sheds light on oral medical therapy in diverse diseases by endowing organic and inorganic nanomaterials with more possibility to enhance oral bioavailability.image

Automated summary

This article discusses the advantages and limitations of oral administration compared to injection, as well as the application of nanotechnology in improving the bioavailability of oral medicines. In addition, the article also presents the challenges and opportunities in the future development of oral nanomedicine.